FR3066118B1 - SECHIUM EDULE EXTRACT TO COMBAT THE HARMFUL EFFECTS OF ULTRAVIOLET RADIATION - Google Patents

SECHIUM EDULE EXTRACT TO COMBAT THE HARMFUL EFFECTS OF ULTRAVIOLET RADIATION Download PDF

Info

Publication number
FR3066118B1
FR3066118B1 FR1754232A FR1754232A FR3066118B1 FR 3066118 B1 FR3066118 B1 FR 3066118B1 FR 1754232 A FR1754232 A FR 1754232A FR 1754232 A FR1754232 A FR 1754232A FR 3066118 B1 FR3066118 B1 FR 3066118B1
Authority
FR
France
Prior art keywords
combat
extract
ultraviolet radiation
harmful effects
sechium edule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1754232A
Other languages
French (fr)
Other versions
FR3066118A1 (en
Inventor
Nicolas Bechetoille
Frederic Demarne
Elodie Metral
Walid Rachidi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gattefosse SA
Hospices Civils de Lyon HCL
Commissariat a lEnergie Atomique et aux Energies Alternatives CEA
Original Assignee
Commissariat a lEnergie Atomique CEA
Gattefosse SA
Hospices Civils de Lyon HCL
Commissariat a lEnergie Atomique et aux Energies Alternatives CEA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commissariat a lEnergie Atomique CEA, Gattefosse SA, Hospices Civils de Lyon HCL, Commissariat a lEnergie Atomique et aux Energies Alternatives CEA filed Critical Commissariat a lEnergie Atomique CEA
Priority to FR1754232A priority Critical patent/FR3066118B1/en
Publication of FR3066118A1 publication Critical patent/FR3066118A1/en
Application granted granted Critical
Publication of FR3066118B1 publication Critical patent/FR3066118B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/42—Cucurbitaceae (Cucumber family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Extrait de Sechium edule et son utilisation dans une méthode de traitement pour lutter contre les effets nocifs des rayonnements ultraviolets sur la peau.Sechium edule extract and its use in a treatment method to combat the harmful effects of ultraviolet radiation on the skin.

FR1754232A 2017-05-15 2017-05-15 SECHIUM EDULE EXTRACT TO COMBAT THE HARMFUL EFFECTS OF ULTRAVIOLET RADIATION Active FR3066118B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1754232A FR3066118B1 (en) 2017-05-15 2017-05-15 SECHIUM EDULE EXTRACT TO COMBAT THE HARMFUL EFFECTS OF ULTRAVIOLET RADIATION

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1754232 2017-05-15
FR1754232A FR3066118B1 (en) 2017-05-15 2017-05-15 SECHIUM EDULE EXTRACT TO COMBAT THE HARMFUL EFFECTS OF ULTRAVIOLET RADIATION

Publications (2)

Publication Number Publication Date
FR3066118A1 FR3066118A1 (en) 2018-11-16
FR3066118B1 true FR3066118B1 (en) 2020-05-15

Family

ID=59253781

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1754232A Active FR3066118B1 (en) 2017-05-15 2017-05-15 SECHIUM EDULE EXTRACT TO COMBAT THE HARMFUL EFFECTS OF ULTRAVIOLET RADIATION

Country Status (1)

Country Link
FR (1) FR3066118B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3133539A1 (en) 2022-03-21 2023-09-22 Gattefosse Sas Plant extract obtained by a process using a supramolecular solvent, the extract comprising at least one exogenous polysaccharide

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5124810B2 (en) * 2006-10-10 2013-01-23 独立行政法人産業技術総合研究所 Endothelin-1 production inhibitor
KR100984163B1 (en) * 2010-02-11 2010-09-28 (주)뉴로코스메틱 Humectant cosmetic composition comprising chayote extract and manufacturing method thereof
FR3036618B1 (en) * 2015-05-26 2018-11-02 Gattefosse S.A.S. VEGETABLE EXTRACTS FOR COSMETICS, SOLVENTS AND METHODS FOR OBTAINING SAME

Also Published As

Publication number Publication date
FR3066118A1 (en) 2018-11-16

Similar Documents

Publication Publication Date Title
MX2021006581A (en) Bacteria engineered to treat diseases associated with hyperammonemia.
EP3369491A4 (en) Environmentally-friendly medical waste treatment apparatus and method specific to medical institutions
IL262562A (en) Combination of anti-pd-1 antibodies and radiation to treat cancer
IL268138A (en) Combinations of cabozantinib and atezolizumab to treat cancer
PH12017500803A1 (en) Anti-pd-1 antibodies
MX2017007707A (en) Method for predicting response to breast cancer therapeutic agents and method of treatment of breast cancer.
GEP20217317B (en) Combination therapy for the treatment of cancer
EA201790010A1 (en) GAMMA-DELTA T-CELLS AND THEIR APPLICATION
MX2017006015A (en) Apilimod for use in the treatment of renal cancer.
SG10201908584SA (en) Fixed Dose Combinations And Formulations Comprising ETC1002 And One Or More Statins And Methods Of Treating Or Reducing The Risk Of Cardiovascular Disease
IL252535A0 (en) Combination of anti-cs1 and anti-pd1 antibodies to treat cancer (myeloma)
ZA201703467B (en) Methods of treating ocular conditions
IL263394A (en) Methods of activating dysfunctional immune cells and treatment of cancer
IL251736B (en) Methods and compositions for the treatment of radiation-related disorders
GB201522152D0 (en) Improvements in and relating to waste treatment
SG11201704486TA (en) Improvements in and relating to the treatment of matrices and/or the contents of matrices
FR3066118B1 (en) SECHIUM EDULE EXTRACT TO COMBAT THE HARMFUL EFFECTS OF ULTRAVIOLET RADIATION
PH12016501658A1 (en) Sialylated glycoprotein compositions and uses thereof
GB201617622D0 (en) Means and methods to treat inflammation
FR3030270B1 (en) COSMETIC TREATMENT PROCESS AND KIT THEREFOR
ZA201708516B (en) Specific photoimmuno-theranostics for detection and elimination of skin cancer cells
FR3030280B1 (en) FILMOGENE COMPOSITION AND USE THEREOF FOR THE TREATMENT OF BUCCO-LINGUAL DISEASES
PT3162210T (en) Treatment to improve the germination of seeds and seeds treated in this way
MX2018014991A (en) Adoptive cell therapies as early treatment options.
GB201709357D0 (en) Improvements in and relating to waste treatment

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20181116

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7